Zobrazeno 1 - 10
of 239
pro vyhledávání: ''
Autor:
Francesco Vasuri, Rosanna Cogliandro, Giovanni Marasco, Lara Bellacosa, Giovanni Barbara, Cesare Cremon, Federica Capuani, Paula Antonia Mauloni, Vincenzo Stanghellini, Clara Paone
Publikováno v:
European journal of gastroenterologyhepatology. 33(1S Suppl 1)
Olmesartan is an angiotensin II receptor blocker, approved in 2002 by the Food and Drug Administration for the treatment of hypertension. During chronic therapy with olmesartan, sprue-like enteropathy can occur, being mainly characterised by non-bloo
Autor:
and Descript, Armand Garioud, Study Groups, Jean-Pierre Arpurt, Descript, Jean Henrion, Olivier Chazouillères, Christophe Corpechot, Alexandre Pariente, Christophe Renou, Isabelle Rosa, Xavier Causse, Bertrand Hanslik
Publikováno v:
European journal of gastroenterologyhepatology. 33(1S Suppl 1)
BACKGROUND AND AIMS To assess the characteristics, care, treatment response, and outcomes of primary biliary cholangitis (PBC) patients recently followed-up by hepato-gastroenterologists in various French and Belgian healthcare settings. METHODS This
Autor:
Raquel Gaio, Sofia Carvalhana, Helena Cortez-Pinto, Paulo Nogueira, Miguel Carneiro de Moura, Luís Carlos Freitas, Daniela Reis, Rui Tato Marinho
Publikováno v:
European journal of gastroenterologyhepatology. 33(1S Suppl 1)
BACKGROUND AND AIMS Sorafenib, used for advanced-stage hepatocellular carcinoma (HCC), has an overall survival (OS) of 10 months. However, some patients have better response and long-term survival (LTS). Aims to assess predictive factors for LTS. MET
Efficiency of azathioprine monotherapy for maintenance treatment of autoimmune hepatitis in children
Autor:
Büşra Emir, Gokhan Tumgor, Betül Aksoy, Maşallah Baran, Murat Cakir, Burcu Güven, Yeliz Cagan Appak, Sibel Yavuz, Elif Sag
Publikováno v:
European journal of gastroenterologyhepatology. 34(1)
Introduction Autoimmune hepatitis (AIH) is a common pediatric liver disease and long-term remission is usually maintained with low dose prednisolone and azathioprine (AZA). The aim of this study is to evaluate the efficiency of AZA monotherapy for ma
Publikováno v:
European journal of gastroenterologyhepatology. 32(4)
The present study was conducted to compare the efficacy and side effects of Spironolactone and Eplerenone in management of ascites due to liver cirrhosis.105 patients of ascites with liver cirrhosis were randomized into three groups of 35 patients ea
Autor:
Claus Mees, Niels Weller, Matthias Doll, Christel Weiß, Dorothea Schmidt, Peter Prinz, Stephan Werle, Daniel Schmitz, Andreas Günther, Barbara John, Jochen Rudi
Publikováno v:
European journal of gastroenterologyhepatology. 32(4)
Objectives Epinephrine injection is the therapy of first choice in post sphincterotomy bleeding (PSB), but may not be efficient in all cases and can cause postprocedural myocardial infarction. Plastic stent insertion (PSI) may be a better treatment.
Autor:
Jun Yong Park, Won Dong Lee, Sang Hoon Ahn, Seung Up Kim, Do Young Kim, Kwang Hyub Han, Beom Kyung Kim
Publikováno v:
European journal of gastroenterologyhepatology. 32(12)
Background and aims Rosuvastatin plus ezetimibe are beneficial for the management of dyslipidemia. We investigated whether rosuvastatin plus ezetimibe improves hepatic steatosis in patients with dyslipidemia. Methods Between January and August 2018,
Autor:
Ido Lish, Fabiana Benjaminov, Lihi Bar-Lev Schleider, Fred M. Konikoff, Yehuda Ringel, Timna Naftali
Publikováno v:
European journal of gastroenterologyhepatology. 31(11)
OBJECTIVE Use of medical cannabis for improving symptoms of inflammatory bowel disease is increasing. However, reports on long-term outcomes are lacking. This prospective, observational study assessed the effects of licensed cannabis use among patien
Autor:
P Hoffmann, Fabian Schoenefuss
Publikováno v:
European journal of gastroenterologyhepatology. 31(12)
Background Loss of response to anti-TNFα treatment occurs frequently in IBD- patients. We evaluatedthe predictive value of serum albumin and γ-globulin concentrations for treatment failure. Methods Prospectively, all patients treated for the first
Autor:
Hamid Asadzadeh Aghdaei, Mohammad Abbasinazari, Behzad Hatami, Saeed Abdi, Mehrnaz Rasoolinezhad, Saeede Saadati, Amir Sadeghi, Shaghayegh Jamshidzadeh
Publikováno v:
European journal of gastroenterologyhepatology. 31(11)
Objective Post-ERCP pancreatitis (PEP) is the most prevalent complication of endoscopic retrograde cholangiopancreatography (ERCP). Melatonin has been mentioned as a protective factor against acute pancreatitis. The present study was conducted to det